Radiopharmaceuticals and the PET probe in the detection of Ductal Carcinoma in situ of the breast
MetadataShow full item record
The use of a hand-held positron emission tomography (PET) probe during breast surgery can potentially reduce the rate of second operations, having a number of implications. The PET probe tested in ductal carcinoma in situ (DCIS) surgery demonstrated to be 96.5% accurate when compared to pathology. This research examines the current technology available, the epidemiology of DCIS in Western Australia, testing of the radiopharmaceutical used with the probe and the PET probe itself.
Showing items related by title, author, creator and subject.
Pettersen, Jade Kristin (2010)Several resorcinarene and calixarene based receptors were synthesised with the overarching aim of developing selective hydrocarbon sensors for application in the petroleum exploration industry.Thioacetyl resorcinarenes ...
Bader, M.; Ehrenbergher, W.; Bitter, R.; Stevens, J.; Miller, Ben; Chopard, J.; Ruger, S.; Hardy, G.; Poot, P.; Dixon, Kingsley; Zimmermann, U.; Veneklaas, E. (2014)Southwest Australian Banksia woodlands are highly diverse plant communities that are threatened by drought- or temperature-induced mortality due to the region's changing climate. We examined water relations in dominant ...
Müller, M.; Saxey, David; Cerezo, A.; Smith, G. (2010)Laser-pulsed atom probe tomography is introduced as a novel tomographic technique and its basic principles are explained. Atom probe provides 3-dimensional chemical maps with nanoscale resolution. For semiconductor research, ...